8-K
Current Report
Aligos Therapeutics, Inc. Filed Acc 0001193125-22-182802
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading d356477d8k.htm…